Spectral karyotyping in patients with acute myeloid leukemia and a complex karyotype shows hidden aberrations, including recurrent overrepresentation of 21q, 11q, and 22q

被引:79
作者
Mrózek, K
Heinonen, K
Theil, KS
Bloomfield, CD
机构
[1] Ohio State Univ, Div Hematol & Oncol, Columbus, OH 43210 USA
[2] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA
[3] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA
关键词
D O I
10.1002/gcc.10027
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We used spectral karyotyping (SKY) to study 29 adults with acute myeloid leukemia and a complex karyotype containing one to nine abnormalities that were not fully identifiable by G-banding. SKY showed the origin of rings and unidentified material in unbalanced translocations in all cases and the origin of markers in most, allowing reinterpretation of 136 aberrations and discovery of three aberrations hidden in normal chromosomes. SKY confirmed 10 and refined the interpretation of three balanced aberrations recognized by G-banding and identified another nine balanced aberrations, including a novel translocation involving the RUNXI gene. Eleven of 32 deletions found by G-banding were shown to be cryptic translocations or insertions, including three of four chromosome 3 deletions, two of three del(7q), and two of 12 del(5q). Of the 92 chromosomes deemed lost entirely by G-banding, 63 (68%) were shown to be involved in structural aberrations. This was especially true for -21 (eight of eight patients), -5 (five of six patients), -20 (seven of nine patients), and -18 (six of 12 patients). Unexpectedly, SKY uncovered a hidden overrepresentation of segments from at least one chromosome in 2 1 patients. The most frequently overrepresented was 21q, found in eight patients, including four with high-level 21q amplification. Fluorescence in situ hybridization showed that the RUNXI gene was not the target of amplification in seven of these patients. Also frequently gained were 11q (in seven patients, including three with high-level MLL gene amplification) and 22q (in seven patients). We conclude that SKY considerably enhances the accuracy of karyotype interpretation, and that amplification of chromosomal material may play a greater role in leukemogenesis than has been recognized. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:137 / 153
页数:17
相关论文
共 43 条
[1]   Establishment and characterization of a megakaryoblast cell line with amplification of MLL [J].
Allen, RJ ;
Smith, SD ;
Moldwin, RL ;
Lu, MM ;
Giordano, L ;
Vignon, C ;
Suto, Y ;
Harden, A ;
Tomek, R ;
Veldman, T ;
Ried, T ;
Larson, RA ;
Le Beau, MM ;
Rowley, JD ;
Zeleznik-Le, N .
LEUKEMIA, 1998, 12 (07) :1119-1127
[2]   Fluorescence in situ hybridization analyses of hematologic malignancies reveal frequent cytogenetically unrecognized 12p rearrangements [J].
Andreasson, P ;
Johansson, B ;
Billström, R ;
Garwicz, S ;
Mitelman, F ;
Höglund, M .
LEUKEMIA, 1998, 12 (03) :390-400
[3]  
Avet-Loiseau H, 1999, GENE CHROMOSOME CANC, V26, P166, DOI 10.1002/(SICI)1098-2264(199910)26:2<166::AID-GCC9>3.0.CO
[4]  
2-P
[5]  
Bloomfield CD, 1998, CANCER RES, V58, P4173
[6]  
Caligiuri MA, 1996, CANCER RES, V56, P1418
[7]   Monosomy 20 as a pointer to dicentric (9;20) in acute lymphoblastic leukemia [J].
Clark, R ;
Byatt, SA ;
Bennett, CF ;
Brama, M ;
Martineau, M ;
Moorman, AV ;
Roberts, K ;
Secker-Walker, LM ;
Richards, S ;
Eden, OB ;
Goldstone, AH ;
Harrison, CJ .
LEUKEMIA, 2000, 14 (02) :241-246
[8]   MLL amplification in acute leukaemia:: a United Kingdom Cancer Cytogenetics Group (UKCCG) study [J].
Cuthbert, G ;
Thompson, K ;
McCullough, S ;
Watmore, A ;
Dickinson, H ;
Telford, N ;
Mugneret, F ;
Harrison, C ;
Griffiths, M ;
Bown, N .
LEUKEMIA, 2000, 14 (11) :1885-1891
[9]   Reassessment of childhood B-Lineage lymphoblastic leukemia karyotypes using spectral analysis [J].
Elghezal, H ;
Le Guyader, G ;
Radford-Weiss, I ;
Perot, C ;
Van den Akker, J ;
Eydoux, P ;
Vekemans, M ;
Romana, SP .
GENES CHROMOSOMES & CANCER, 2001, 30 (04) :383-392
[10]   NOVEL TRANSLOCATION (2-4) WITH CONSISTENT INVOLVEMENT OF 2P23 IN ACUTE NONLYMPHOCYTIC LEUKEMIA (M2) [J].
FARAG, S ;
CHALLIS, J ;
WHITE, J ;
GARSON, OM .
CANCER GENETICS AND CYTOGENETICS, 1992, 58 (01) :48-51